Showing 7111-7120 of 9247 results for "".
Expanding Access to Care Through a Virtual Platform
https://practicaldermatology.com/videos/c-suite-chats/expanding-access-to-care-through-a-virtual-platform/69071/Patrick Burnett, MD, PhD, FAAD, Chief Medical Officer for Arcutis, discusses a new virtual health platform designed to expand access pathways to roflumilast for chronic inflammatory skin diseases.Prurigo Nodularis, Chronic Itch, and Lymphoma Risk
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/prurigo-nodularis-chronic-itch-and-lymphoma-risk/50965/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Lawrence Green, MD, FAAD, examine the link between prurigo nodularis, chronic pruritus, Type 2 inflammation, and lymphoma risk, with a focus on evaluating the underlying causes of persistent itch.Addressing Unmet Needs in Rare Skin Diseases
https://practicaldermatology.com/videos/c-suite-chats/addressing-unmet-needs-in-rare-skin-diseases/67376/LEO Pharma VP of Rare Disease Lukasz Jarzyna discusses an industry shift toward the massive, untapped market of unmet needs in rare skin diseases such as generalized pustular psoriasis and the current awareness campaign around that particular condition.Zasocitinib Psoriasis Studies Continue to Show Promise
https://practicaldermatology.com/videos/skin-minute/zasocitinib-psoriasis-studies-continue-to-show-promise/67371/Linda Stein Gold, MD, explains the significance of new Phase 3 data on zasocitinib for psoriasis, demonstrating consistent, high rates of skin clearance across the body, including hard-to-treat and high-impact sites.Increasing Exposure for Genital Psoriasis
https://practicaldermatology.com/videos/skin-minute/increasing-exposure-for-genital-psoriasis/67119/Michael J. Payette, MD, MBA, discusses a paper he authored in the American Journal of Clinical Dermatology that provides clinically practical, age-specific guidance for diagnosing and managing genital psoriasis across pediatric, adult, and older populations.Evolving Atopic Dermatitis Therapeutic Capabilities
https://practicaldermatology.com/videos/c-suite-chats/evolving-atopic-dermatitis-therapeutic-capabilities/67100/J. Mark Jackson, MD, FAAD, Senior Vice President, Clinical Development for Evommune, discusses the importance of improved efficacy and safety for underserved patients with atopic dermatitis.Rezpegaldesleukin for the Treatment of Atopic Dermatitis
https://practicaldermatology.com/videos/skin-minute/rezpegaldesleukin-for-the-treatment-of-atopic-dermatitis/61143/Dr. Jonathan Silverberg talks about the maintenance data from REZOLVE-AD trial showing lasting efficacy in patients treated with rezpegaldesleukin across several disease measurements of atopic dermatitis (AD).How to Get Young People to Wear Sunscreen
https://practicaldermatology.com/videos/skin-minute/how-to-get-young-people-to-wear-sunscreen/60875/SPOOGE Founder Whitney Hovenic, MD, discusses younger generations' insufficient utilization of sunscreen and the strategies her company has employed in an effort to avoid an increase in melanoma cases in the future.Exploring Dupilumab's Impact on Growth in Pediatric Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/exploring-dupilumabs-impact-on-growth-in-pediatric-atopic-dermatitis/50962/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Michelle Tarbox, MD, FAAD, discuss emerging evidence and real-world experiences demonstrating how effective control of atopic dermatitis with dupilumab may support healthy growth and development in pediatric patieTreating Chronic Inflammatory Diseases
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/treating-chronic-inflammatory-diseases/57011/Natasha Mesinkovska, MD, provides insight into the treatment of chronic inflammatory diseases.